• Home
  • About us
  • Our products
  • Your health
  • Responsibility
  • In the community
  • Research & development
  • Investors
  • Media centre
  • Careers
GlaxoSmithKline logo

Economic indicators

This table shows which elements of the Global Reporting Initiative guidelines are covered in our report
or elsewhere on the GSK website.

GRI guideline     Covered? Link
5. Performance: Economic
Customers
EC1 Core Net sales Yes About GSK and
Annual report
EC2 Core Geographic breakdown of markets. (For each product or product range, disclose national market share by country where this is 25% or more. Disclose market share and sales for each country where national sales represent 5% or more of GDP) Yes Annual report
Suppliers
EC3 Core Cost of all goods, materials, and services purchased No  
EC4 Core Percent of contracts that were paid in accordance with agreed terms (e.g. scheduling of payments, form of payment etc) Partial Payment performance covered in annual report (page 73)
EC11 Additional Supplier breakdown by organisation and country No  
Employees
EC5 Core Total payroll and benefits expense (incl. wages, pension, redundancy payments) Yes Annual report
Providers of capital
EC6 Core Distributions to providers of capital broken down by interest on debt and borrowings, and dividends on all classes of shares Yes Annual report
EC7 Core Increase/ decrease in retained earnings at end of period Yes Annual report
Public sector
EC8 Core Total sum of taxes of all types paid, broken down by country Partial Data broken down for UK and overseas:

Annual report
EC9 Core Subsidies received broken down by country or region No  
EC10 Core Donations to community, civil society, and other groups broken down in terms of cash and in-kind donations per type group Yes Value of community investment
EC12 Additional Total spent on non-core business infrastructure development e.g. hospital/school for employees and their families No  
Indirect economic impacts
EC13 Additional  Describe the organisation's indirect economic impacts No  
< Previous page     Next page >

* Back to top